Synthesize Bio

Synthesize Bio

Private
Seattle, WashingtonAI, Data & Cloud Infrastructurehttps://www.synthesize.bio/

Last Round

Seed

Sep 17, 2025

Total Funding Raised

$10M

Company Overview

Synthesize Bio is a biotechnology company that is building a generative AI platform to engineer biology.

Sector

AI, Data & Cloud Infrastructure

Verticals

Biotechnology, Drug Discovery, Medical AI, Synthetic Data, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Foundation

Keywords

generative genomicsbiological foundation modelgenerative biologyAI drug discoverysynthetic gene expressionin silico simulationbio foundation modeldrug discovery platformbiotech AIin silico biologysynthetic biological datacomputational biologytarget discoveryclinical trial simulationRNA-seq dataprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synthesize Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Synthesize Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 17, 2025

Key People

Founding team and executive leadership

Jeff Leek

Co-CEO Co-Founder

Founding Team

Alice Walsh

Chief Operating Officer

Executive Team

Synthesize Bio Investors

Notable investors and investment history

Synthesize Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synthesize Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synthesize Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range17
Year Founded2023
Last FundingSep 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.